National Cancer Institute now dedicated to treating Childhood Cancer

National Cancer Institute

Children are representatives of their elders and are the leaders of a time that we cannot see. However, this may not be true for all children, as some are in the grasp of cancer.

Considering the global impact of cancer in people’s lives, the National Cancer Institute (NCI) is dedicated to reducing the number of cancer patients in the US and funding collaboration between researchers from different parts of the world and focusing them on childhood cancer. By doing so, they can be able to accelerate any progress that has been made so far and ensure a long, healthy lifestyle for children.

The US has made many technological advancements in this sector, like the HPV vaccine. This vaccine is used to prevent adult cancers such as cervical cancer. However, this will only be an achievement if it is provided to areas where cervical cancer, along with breast cancer in mothers, is a frequent cause of death. This may result in children’s mortality rate rising above 10%. Many other types of cancers, however rare in the US, are very common in underprivileged areas like Africa.

This research aims at developing effective, yet less toxic treatments for children with cancer. Many research trials resulted in benefits for cancer patients in other countries as well. However, these trials can be hard to achieve as a significant number of patients are required for an accurate answer.

For instance, an NCI-supported clinical trial recently showed that children with liver cancer need comparatively less chemotherapy as compared to children with other types of cancer. Children with liver cancer have been getting the same amounts of chemo, but it hasn’t caused any harm to their long term life. More research is still being carried out in other parts of the world including North America, Japan, Australia, and Europe.

Research teams supported by NCI have been working day and night in hopes of reducing the burden of cancer on the world. The next goal is to research leukemia, rhabdomyosarcoma, and others that attack children.

, , ,